Human bone marrow mesenchymal stromal cells (MSCs) have been used in clinical trials for the treatment of systemic inflammatory diseases due to their regenerative and immunomodulatory properties. However, intravenous administration of MSCs is hampered by cell trapping within the pulmonary capillary networks. Here, we hypothesize that traditional twodimensional (2D) plastic-adherent cell expansion fails to result in appropriate morphorheological properties required for cell-circulation. To address this issue, we adapted a novel method to culture MSCs in non-adherent three-dimensional (3D) spheroids (mesenspheres).
Introduction
Mesenchymal stromal cells (MSCs) are described as a population of multipotent cells within almost all tissues, that distinguish themselves from other tissue residing cells by their unique morphology, fibroblast colony forming unit (CFU-F) capacity, multilineage differentiation potential (1, 2) , and immunomodulatory properties (3) . They suppress alloantigen-induced T cell proliferation (4) , modulate terminal B cell differentiation (5) and inhibit the functions of natural killer cells (6) and dendritic cells (7) via the secretion of soluble factors (8, 9) , and direct cell-cell interactions (10) . Owing to their immunosuppressive effects and tissue regenerative potential, MSCs have been used in clinical trials testing therapies for various diseases including graft-versus-host disease after allogenic stem cell transplantation (11, 12) , autoimmune diseases (13) , liver diseases (14) , orthopedic injuries (15) , cardiovascular diseases (16) , and cancer (17) . For these applications, high numbers of MSCs are required, for which they are commonly isolated from tissues of healthy human donors including bone marrow (BM) explants and expanded on rigid plastic surfaces as adherent monolayer (2D) cultures. This process is associated with depletion of less adherent earlier progenitors (18) .
Moreover, recent work has shown that long-term culturing on rigid substrates fails to resemble the natural three-dimensional (3D) bone marrow microenvironment with its unique tissue architecture and mechanical properties. This leads to reduced growth rates, loss of multipotency, and cellular senescence (19, 20) . The most eminent disadvantages, however, are alterations in the cytoskeletal organization and the morpho-rheological phenotype, such as cell size and compliance (21) . Intravenous infusion of such expanded MSCs is followed by cell trapping within the pulmonary microcirculation and inefficient homing to target organs in mice (22, 23) and humans (24) .
The cell's morpho-rheology has moved into the focus of attention since recent work identified them as key regulators of cell migration (25) , immune response (26) and cell polarization (27) .
Changes in cell deformability, especially cell softening, not only accompany cell differentiation (28) and motility they also improve cell passage through microcapillaries (29) . This raises the question whether engineering MSCs with circulation-appropriate morpho-rheological properties can improve microcirculation. As a cell's morphology and mechanical state depend highly on environmental physical properties and the resulting extracellular to intracellular signaling (30) , we asked whether the modulation of morpho-rheological features can be achieved using innovative cell culture techniques. Expansion of MSCs in 3D spheroidal aggregates compared to traditional 2D techniques results in cells with smaller size (31, 32) and reduced Young's modulus (33) . Therefore, we adapted a scaffold-free 3D cell culture system for the monoclonal expansion of MSCs in non-adherent spheroids (mesenspheres).
We identified that 3D-expanded cells fulfill properties of MSCs including self-renewability, multilineage differentiation and immune modulation. Based on our findings of cytoskeletal rearrangement in 3D-expanded MSCs, we compared morpho-rheological properties of MSCs after scaffold-free 3D and traditional 2D expansion. Using atomic force microscopy (AFM) indentation measurement and real-time deformability cytometry (RT-DC), we found that 3Dexpanded MSCs are smaller and more compliant. Ex vivo microcirculation analysis revealed that mesensphere-forming single cells compared to plastic-adherent MSCs required less time to enter and pass a microfluidic microcirculation mimetic (MMM) device. Furthermore, we demonstrated that after intravenous injection of MSCs in the tail vein of mice, mesenspherederived MSCs were detected to a larger amount in the microcirculation of various organs other than the lungs. In this respect, the unique morpho-rheological properties of mesensphereexpanded MSCs make them amenable for the development of advantageous stem cell therapies to overcome limitations that arise with traditional 2D cultures.
Results

Mesenspheres comprise multipotent, self-renewable and immunomodulatory MSCs capable of hematopoietic stem and progenitor cell support
Mesenchymal stromal cell spheroids (mesenspheres) were cultured from bone marrow (BM) mononuclear cell (MNC) fraction isolated by density gradient centrifugation. Enrichment of MSCs was achieved by immunomagnetic depletion of CD45-positive MNCs. Utilizing ultra-low attachment flasks and mesensphere growth medium, CD45-depleted MNCs formed selfassembled spherical-shaped mesenspheres. Hematoxylin and eosin (H&E) staining of paraffin-embedded sections revealed that mesenspheres build a compact 3D network composed of small round cells surrounded by elongated flat cells ( Figure 1A ). To determine the frequency of mesenchymal progenitors, we performed CFU-F assay. Mesenspherederived MSCs were found to establish multiple fibroblast colonies with various sizes. Using limiting dilution analysis (ELDA) (34) the estimate of stem cell frequency in mesenspheres was 1/82.7 cells with 95% confidence interval of 1/50.9 to 1/134 cells ( Figure 1B ). According to the minimal criteria for MSCs (35) , mesensphere cells were found positive for surface marker expression of CD105 (85.5% ± 8.5%), CD73 (94.3% ± 5.7%), and CD90 (85% ± 16%) and lack expression of CD14 (4.6% ± 1.2%), CD19 (2.2% ± 2%), CD34 (2.5% ± 1.6%), CD45 (4.2% ± 5%) and HLA-DR (13.4% ± 12.4%; Figure 1C ). Moreover, we found that mesenspheres exhibit multilineage differentiation potential (Figure S1A-E). Immunomodulatory properties of mesensphere-derived MSCs were investigated using a modified mixed lymphocyte reaction assay (36). Lymphocyte proliferation as measured by [ 3 H]-thymidine incorporation was significantly decreased in the presence of mesensphere MSCs (44097.7 cpm ± 23200.0 vs. 63718.3 cpm ± 32461.1; p = 0.0044; Figure 1D ). Furthermore, BM-derived MSCs have been shown to support hematopoietic stem and progenitor cell (HSPC) maintenance and engraftment (37) . We found that clonogenic HSPCs with appropriate differentiation potential could be efficiently expanded in co-culture with mesenspheres ( Figure S2A 
Mesensphere-derived MSCs exhibit characteristic morpho-rheological properties
It has been shown that the size and cytoskeletal proteins of MSCs maintained in 3D (mesenspheres) are drastically reduced compared to 2D (31, 38) . Therefore, we studied whether mesensphere culture of MSCs also affects other relevant morpho-rheological properties that can influence microcirculation. Analysis of the cytoskeleton distribution in entire mesenspheres revealed short, tightly bundled actin filaments in the apical mesensphere region. Towards the mesensphere interior actin filaments assembled as cell cortex associated ring-like belt structures (Figure 2A ). In contrary, in plastic-adherent MSCs, we observed uniformly distributed actin stress fibers, namely dorsal stress fibers, transverse arcs and ventral stress fibers ( Figure 2B ). Since cytoskeletal mutations directly correlate with morphorheological properties (29, 39, 40) , we performed atomic force microscopy (AFM) indentation measurements on single MSCs in entire mesenspheres and MSCs cultured on rigid plastic surfaces to probe cell stiffness ( Figure 2C ). The morpho-rheological properties were quantified by extracting the apparent Young's modulus from the obtained force-indentation curves. As demonstrated in Figure 2D , apparent Young's moduli measured for mesenspheres were significantly lower compared to plastic-adherent MSCs (761.4 Pa ± 542.4 vs. 5926 Pa ± 486.9, p = 4.9x10 -8 ). Interestingly, the apparent Young's moduli of mesensphere cells that had been migrated out of mesenspheres after 5 hours were increased compared to cells within mesenspheres (1871 Pa ± 971.1 vs. 761.4 ± 542.4, p = 0.001), which identifies plastic adherence as a main contributor of cell mechanics. Furthermore, morpho-rheological properties of suspended MSCs were analyzed using real-time deformability cytometry (RT-DC) ( Figure 2E ). Here, the apparent Young's modulus can be derived from image analysis that quantified cell size and the resulting deformation as cells pass through a narrow microfluidic channel, similar to blood flow, in real-time and with high-throughput (up to 1,000 cells/sec) (39, 41, 42) . In comparison with plastic-adherent MSCs, mesensphere-derived MSCs appeared significantly smaller (cross-sectional area: 290,5 µm 2 ± 34,9 vs. 391,02 µm 2 ± 30,4, p = 0.0008, Figure 2F ) and more deformable (deformation: 0.056 ± 0.006 vs. 0.041 ± 0.004, p = 0.0166, apparent Young's modulus: 1129.6 ± 135.0 Pa vs. 1812.6 Pa ± 98.0, p = 0.0002, Figure 2G -H). So far, it has been assumed that the large size of MSCs cultured on rigid 2D plastic surfaces causes trapping within the pulmonary capillaries (23). However, our previous studies indicate that in addition to cell size, also the cell mechanical properties affect microcirculation (29) . Therefore, we hypothesized that altered morpho-rheological properties of MSCs cultivated in mesenspheres can improve microcirculation. 
Morpho-rheological properties of mesensphere-derived MSCs permit cell circulation
To analyze the impact of the culture system, and the resulting altered morpho-rheological properties, on MSC circulation, we mimicked pulmonary microcirculation in a microfluidic device, namely microfluidic microcirculation mimetic (MMM). MMM consists of a serpentine microchannel 300 µm in total length and 20 µm in height and 20 µm in width with 187 successive constrictions smaller than the cell diameter (5 µm in cross section; Figure 3A ) (43, 44) . Thus, the constrictions and therefore the cell deformations occur sequentially one after the other as in the microcirculation. Cells were re-suspended in PBS and flushed through the MMM using a constant pressure difference of 150 mBar between the inlet and the outlet. To quantify the ability of cells to pass through the constrictions, we measured entry time (time that is needed to pass the first constriction of the microchannel) and total passage time.
Mesensphere MSCs were found to require less time to enter the first constriction (0.035 sec ± 0.0127 vs 0.106 sec ± 0.0261, p = 0.0077) and less time to pass the whole microchannel To further investigate whether the unique morpho-rheological properties of mesenspherederived MSCs promote increased microcirculation, MSCs derived from mesenspheres or plastic-adherent cultures were dissociated to obtain single-cell suspensions and injected intravenously into the tail vein of NSG mice ( Figure 4A ). After 15 min mice were sacrificed, organs were dissected, and DNA was isolated to quantify human Alu-sequences within tissues.
As depicted in Figure 4B 
Discussion
Since Friedenstein et al. first described MSCs as a clonogenic population of BM-derived cells (45) , they have been applied in numerous clinical trials due to their regenerative and immunomodulatory potential. However, prior to the use of MSCs as cell-based therapeutics, considerable hurdles must be overcome such as establishment of standards for cell purification and expansion (46) . These standards include conventional 2D monolayer cultures on rigid tissue culture plastic, which has been linked to loss of MSC function (19) (20) (21) . Therefore, it is crucial to develop physiologically relevant culture environments that maintain MSCs in a more naïve state.
Méndez-Ferrer et al. adapted a culture regime, conducive for the assembly of Nestin+ cells into neurospheroids, for Nestin+ murine and human BM MSCs to obtain mesenspheres (47) .
Using slightly modified culture conditions, we succeeded to obtain mesenspheres derived from CD45-depleted BM-MNC. It is supposed that spheroid generation on low attachment plates starts with loose cell aggregates mediated by ECM-integrin interactions followed by cell compaction via cadherin bindings (38, 48) . The scaffold-free culture of mesenspheres yielded a highly heterogeneous cell population in cell size and cell morphology. Irrespectively, mesensphere forming cells behave functionally like MSCs as shown by their CFU-F capacity, cell surface molecule expression, multilineage differentiation, and HSPC support. Previous studies reported that cell expansion in 3D spheroids even enhances the differentiation potential of multipotent cells (49) . Moreover, it is presumed that the 3D cell culture environment improves the therapeutic potential of MSCs by increased expression of relevant genes such as CXCR4 promoting adhesion to endothelial cells (50) or SCF that is involved in HSPC maintenance (51) . Our analysis demonstrated that mesenspheres express high levels of HSPC-supporting factors and are capable to expand a population containing CD45 + / CD34 + / CD133 + long-term HSPC. Hence, efficient expansion of functional MSCs does not require plastic adherence. MSCs expansion can be achieved using scaffold-free 3D cell culture techniques that mimic the physiological BM microenvironment more closely than plasticadherent 2D monolayer cultures.
Since MSCs can modulate multiple components of the immune system including T-and B-cell proliferation, they emerge as promising candidates for cell-based immunotherapies. Our analysis revealed that mesensphere forming cells effectively suppress T cell proliferation in the same manner as shown for clinical used MSCs grown in 2D monolayers (4) . This suggests that mesensphere MSCs possess immunomodulatory properties that qualifies them as therapeutics for systemic inflammatory diseases such as graft-versus-host disease (GvHD) after allogenic hematopoietic stem cell transplantation.
So far, the most convenient route of administration for traditional 2D-expanded MSCs is intravenous injection. Undesirably, homing to target organs is often impeded by cells trapped within the pulmonary microcapillary networks (22) (23) (24) . Previous studies with neutrophils revealed that stiff primed compared to soft resting neutrophils exhibit longer total passage times in microcirculatory mimetics (44) . Moreover, recent clinical observations provide evidence that primed neutrophils are retained within the pulmonary microcirculation, while deprimed neutrophils are released into the systemic circulation (52). Lautenschläger et al.
found that mobility of neutrophils is facilitated by cell softening, which appeared to be regulated by the actin cytoskeleton (25, 29) . This implies that cell deformability must be crucial for efficient passage kinetics in microcirculation. Notably, mesensphere compared to 2D cultured
MSCs appeared smaller and more deformable. These results agree with previous studies in which plastic-adherent MSCs are described as a little-deformable population after expansion Thus, in future it might be promising to use non-adherent 3D reconstitution techniques for the development of MSC cell-based therapeutic approaches in order to ensure expansion of MSCs with small size and enhanced deformability compared to plastic-adherent MSCs. This will prevent them from getting retained in the lung -the first major organ with an extensive microcirculatory network that MSCs have to pass -and contribute to a more even distribution of MSCs in organ capillary networks after intravenous injection. Therefore, using innovative cell culture techniques modulating the morphological and rheological phenotype of MSCs will significantly increase the feasibility of clinical stem cell therapeutic approaches.
Material and methods
Cell isolation and culture
MSCs were isolated from healthy volunteer donors after obtaining informed written consent (ethical approval no. EK221102004, EK47022007) according to modifications of a previously reported method (54, 55) . Briefly, human bone marrow aspirates were diluted in PBS (Thermo GmbH, Bergisch Gladbach, Germany) on agarose-coated 24-well plates at 37 °C with 5% CO 2 in a water-jacked incubator.
In vitro differentiation
Osteogenesis and adipogenesis were induced by culturing MSCs with the respective differentiation medium for 14 days, as described previously (56) . Briefly, osteogenic differentiation medium contained 10 mM β-glycerophosphate, 1.5 µM dexamethasone (Sigma-Aldrich, St. Louis, USA), 0.2 mM L-ascorbate (Synopharm GmbH, Barsbuettel, Germany) and 10% FCS in DMEM (Thermo Fisher Scientific, Waltham, USA). Adipogenic differentiation was induced with 1 nM dexamethasone, 500 nM 3-isobutyl-1-methylxanthine, 100 nm indomethacin, 1 µg ml -1 insulin (Sigma-Aldrich, St. Louis, USA) and 10% FCS in DMEM. All cultures were kept at 37 °C with 5% CO 2 in a water-jacked incubator. Medium changes were performed weekly.
To quantify osteogenic differentiation potential alkaline phosphatase (ALP) activity was measured as described previously (57) . Briefly, cells were lysed in 1.5 mM Tris, pH 10, containing 1 mM ZnCl 2 , 1 mM MgCl 2 and 1% Triton X-100. Lysates were clarified by centrifugation and aliquots incubated with 3.7 mM 4-nitrophenylphosphate in 100 mM diethanolamine, pH 9.8, containing 0.1% Triton X-100 for 30 minutes at room temperature.
The reaction was stopped with 100 mM NaOH and the release of 4-nitrophenolate measured photometrically at 405 nm. In alignment with the protein concentration ALP activity was calculated using a standard curve prepared with p-nitrophenol. 
Immunomodulatory assay
For immunomodulatory assay a modified mixed lymphocyte reaction (MLR) was performed as described previously (36). Briefly, peripheral blood mononuclear cells (PBMCs) were isolated from healthy volunteer donors after obtaining written consent (ethical approval no. EK206082008 
Microfluidic microcirculation mimetic
Microfluidic microcirculation mimetics (MMM) was used including minor modifications as described previously (43) . In short, MMM is based on a microfluidic device produced using PDMS and standard photolithographic techniques (29) . The microfluidic chip contained an inlet and an outlet connected by a single channel (constriction) with 5 µm smallest in width (maximum width 15 µm). For MMM measurements, single cells were resuspended to a final density of 3 x 10 4 cells ml -1 in PBS containing 0.1% pluronic acid F-127 (Molecular Probes Inc., Eugene, USA). Up to 50 µL of cell suspension was filled into a custom-cut pipette tip (Eppendorf, Hamburg, Germany) and connected to the inlet region of the microfluidic chip.
Using a computerized air pressure control system (MFCS-FLEX; Fluigent, Villejuif, France) connected to the inlet and outlet of the device cells were driven through the constriction at a constant pressure of 200 mBar. The microfluidic chip was mounted on the platform of an inverted microscope, which was connected to a camera (The Imaging Source, Bremen, Germany) to record videos at a frame-rate of 120 frames sec -1 . The first constriction entry time and the total passage time were extracted from the videos using custom-made written codes in MATLAB (The MathWorks, Natick, MA).
Animal experiments
Animal experiments were strictly performed in compliance with the animal experiment permission no. DD24.1-5131/394/14, approved by the Landesdirektion Sachsen. A total of 1 ´ (Table S1) , and 200 ng target template were incubated at 50°C for 2 min and at 95°C for 10 min followed by 40 cycles at 95°C for 15 secs and 60°C for 1 min.
All real-time PCR assays were performed in duplicates. The obtained results were corrected to the transcript level of an internal reference gene (glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or hypoxanthine phosphoribosyltransferse 2 (HPRT2)) to yield ∆CT and normalized to control conditions to generate ∆∆Ct. The relative change in expression was calculated using the formula 2 -∆∆Ct.
Statistical analyses
Despite RT-DC data all statistical analyses were performed using GraphPad Prism Version 5.0 (San Diego, CA, USA).
